Imaging News

Lantheus Holdings announced the FDA has approved the supplemental new drug application for its perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients with suboptimal echocardiograms.

Six biomarkers were associated with baseline and treatment-associated changes in arterial inflammation in patients with rheumatoid arthritis and could be used to predict CVD risk in that population, researchers reported.

Older adults with a coronary artery calcium score of 0 had more favorable aging indices, including normal cognitive function, vascular function and better hearing, compared with those with CAC scores of 1,000 or greater, data show.

Portable bedside MRI showed promise in detecting infarcts revealed on high-field MRI in those with acute ischemic stroke, with better performance on larger sized infarcts, according to a poster from the International Stroke Conference.

Sleep apnea could be an early indicator of cancer therapy-related cardiomyopathy, according to new data presented at the American College of Cardiology Advancing the Cardiovascular Care of the Oncology Patient course.

Toku has obtained CE and UKCA marks for its CLAiR technology to assess cardiovascular disease risk using retinal images, according to a press release.

Read-world data showed that more patients underwent subsequent revascularization after “CT first” evaluation for chest pain vs. other functional testing strategies, researchers reported.

Philips announced it received FDA 510(k) clearance of its next-generation, miniaturized, transesophageal echocardiography transducer which can be used in very small patients and complex ICU cases.

Artificial intelligence may have a role in the early detection of rheumatic heart disease using mitral regurgitation jet analysis, according to study findings published in the Journal of the American Heart Association.

Cook Medical announced its hydrophilic selective catheter is available again for use in the U.S. and Canada.